153 related articles for article (PubMed ID: 38066445)
41. Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation Registry.
Essien UR; Chiswell K; Kaltenbach LA; Wang TY; Fonarow GC; Thomas KL; Turakhia MP; Benjamin EJ; Rodriguez F; Fang MC; Magnani JW; Yancy CW; Piccini JP
JAMA Cardiol; 2022 Dec; 7(12):1207-1217. PubMed ID: 36287545
[TBL] [Abstract][Full Text] [Related]
42. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
[TBL] [Abstract][Full Text] [Related]
43. Adherence to Anticoagulation and Risk of Stroke Among Medicare Beneficiaries Newly Diagnosed with Atrial Fibrillation.
Hernandez I; He M; Brooks MM; Saba S; Gellad WF
Am J Cardiovasc Drugs; 2020 Apr; 20(2):199-207. PubMed ID: 31523759
[TBL] [Abstract][Full Text] [Related]
44. The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: the FinACAF study.
Jaakkola J; Teppo K; Biancari F; Halminen O; Putaala J; Mustonen P; Haukka J; Linna M; Kinnunen J; Tiili P; Aro AL; Hartikainen J; Airaksinen KEJ; Lehto M
Eur Heart J Qual Care Clin Outcomes; 2022 May; 8(3):269-276. PubMed ID: 34677571
[TBL] [Abstract][Full Text] [Related]
45. Association of income and educational levels on initiation of oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study.
Teppo K; Jaakkola J; Biancari F; Halminen O; Linna M; Haukka J; Putaala J; Mustonen P; Kinnunen J; Hartikainen J; Airaksinen KEJ; Lehto M
Br J Clin Pharmacol; 2023 Jan; 89(1):351-360. PubMed ID: 35986926
[TBL] [Abstract][Full Text] [Related]
46. Effects of a reminder to initiate oral anticoagulation in patients with atrial fibrillation/atrial flutter discharged from the emergency department: REMINDER study.
Rezazadeh S; Chew DS; Miller RJH; Klassen S; Pournazari P; Bennett G; Lang E; Quinn FR
CJEM; 2018 Nov; 20(6):841-849. PubMed ID: 30295590
[TBL] [Abstract][Full Text] [Related]
47. Treatment with direct oral anticoagulants or warfarin and the risk for incident diabetes among patients with atrial fibrillation: a population-based cohort study.
Cheung CL; Sing CW; Lau WCY; Li GHY; Lip GYH; Tan KCB; Cheung BMY; Chan EWY; Wong ICK
Cardiovasc Diabetol; 2021 Mar; 20(1):71. PubMed ID: 33766030
[TBL] [Abstract][Full Text] [Related]
48. Clinical Prediction Model for Time in Therapeutic Range While on Warfarin in Newly Diagnosed Atrial Fibrillation.
Williams BA; Evans MA; Honushefsky AM; Berger PB
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29025746
[TBL] [Abstract][Full Text] [Related]
49. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
Cullen MW; Kim S; Piccini JP; Ansell JE; Fonarow GC; Hylek EM; Singer DE; Mahaffey KW; Kowey PR; Thomas L; Go AS; Lopes RD; Chang P; Peterson ED; Gersh BJ;
Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):461-9. PubMed ID: 23759473
[TBL] [Abstract][Full Text] [Related]
50. Comparative Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin Among Adults With Cancer and Atrial Fibrillation.
Mehta HB; An H; Ardeshirrouhanifard S; Raji MA; Alexander GC; Segal JB
Circ Cardiovasc Qual Outcomes; 2022 Dec; 15(12):e008951. PubMed ID: 36453260
[TBL] [Abstract][Full Text] [Related]
51. Contemporary Management of Direct Oral Anticoagulants During Cardioversion and Ablation for Nonvalvular Atrial Fibrillation.
Trujillo TC; Dobesh PP; Crossley GH; Finks SW
Pharmacotherapy; 2019 Jan; 39(1):94-108. PubMed ID: 30548542
[TBL] [Abstract][Full Text] [Related]
52. Trends in utilization of warfarin and direct oral anticoagulants in older adult patients with atrial fibrillation.
Alalwan AA; Voils SA; Hartzema AG
Am J Health Syst Pharm; 2017 Aug; 74(16):1237-1244. PubMed ID: 28652320
[TBL] [Abstract][Full Text] [Related]
53. Effectiveness and Safety of Anticoagulation Therapy in Frail Patients With Atrial Fibrillation.
Kim D; Yang PS; Sung JH; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Lip GYH; Joung B
Stroke; 2022 Jun; 53(6):1873-1882. PubMed ID: 35109686
[TBL] [Abstract][Full Text] [Related]
54. Incidence and outcomes of patients with atrial fibrillation and major bleeding complications: from the TREAT-AF study.
Perino AC; Kaiser DW; Lee RJ; Fan J; Askari M; Schmitt SK; Turakhia MP
J Interv Card Electrophysiol; 2021 Oct; 62(1):133-142. PubMed ID: 32986177
[TBL] [Abstract][Full Text] [Related]
55. Factors Influencing Oral Anticoagulation Prescription for Patients Presenting to Emergency Departments With Atrial Fibrillation and Flutter.
Miller RJH; Chew DS; Rezazadeh S; Klassen S; Pournazari P; Lang E; Quinn FR
Can J Cardiol; 2018 Jun; 34(6):804-807. PubMed ID: 29801744
[TBL] [Abstract][Full Text] [Related]
56. Oral anticoagulant and reduced risk of dementia in patients with atrial fibrillation: A population-based cohort study.
Mongkhon P; Fanning L; Lau WCY; Tse G; Lau KK; Wei L; Kongkaew C; Wong ICK
Heart Rhythm; 2020 May; 17(5 Pt A):706-713. PubMed ID: 31931172
[TBL] [Abstract][Full Text] [Related]
57. Shifting from vitamin K antagonists to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: predictors, patterns and temporal trends.
Shiyovich A; Shalev V; Chodick G; Tirosh M; Katz A; Klar MM; Shuvy M; Pereg D; Minha S
BMC Cardiovasc Disord; 2021 Oct; 21(1):493. PubMed ID: 34645389
[TBL] [Abstract][Full Text] [Related]
58. Oral anticoagulant underutilization among elderly patients with atrial fibrillation: insights from the United States Medicare database.
Munir MB; Hlavacek P; Keshishian A; Guo JD; Mallampati R; Ferri M; Russ C; Emir B; Cato M; Yuce H; Hsu JC
J Interv Card Electrophysiol; 2023 Apr; 66(3):771-782. PubMed ID: 35804258
[TBL] [Abstract][Full Text] [Related]
59. Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program.
McIntyre WF; Conen D; Olshansky B; Halperin JL; Hayek E; Huisman MV; Lip GYH; Lu S; Healey JS
Clin Cardiol; 2018 Jun; 41(6):744-751. PubMed ID: 29546729
[TBL] [Abstract][Full Text] [Related]
60. Oral Anticoagulant Therapy and Risk of Admission to Long-Term Care in patients With Atrial Fibrillation: A Nationwide Cohort Study.
Teppo K; Airaksinen KEJ; Halminen O; Linna M; Jaakkola J; Haukka J; Putaala J; Mustonen P; Langén VL; Kinnunen J; Hartikainen J; Lehto M
J Am Med Dir Assoc; 2023 Oct; 24(10):1484-1489. PubMed ID: 37348842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
